Publication

Structural model of the dimeric Parkinson's protein LRRK2 reveals a compact architecture involving distant interdomain contacts

Guaitoli, G., Raimondi, F., Gilsbach, B. K., Gómez-Llorente, Y., Deyaert, E., Renzi, F., Li, X., Schaffner, A., Jagtap, P. K. A., Boldt, K., von Zweydorf, F., Gotthardt, K., Lorimer, D. D., Yue, Z., Burgin, A., Janjic, N., Sattler, M., Versées, W., Ueffing, M., Ubarretxena-Belandia, I., Kortholt, A. & Gloeckner, C. J., 26-Jul-2016, In : Proceedings of the National Academy of Sciences of the United States of America. 113, 30, p. E4357-E4366 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Copy link to clipboard

Documents

  • Structural model of the dimeric Parkinson’s protein LRRK2

    Final publisher's version, 2 MB, PDF-document

    Request copy

DOI

  • Giambattista Guaitoli
  • Francesco Raimondi
  • Bernd K. Gilsbach
  • Yacob Gómez-Llorente
  • Egon Deyaert
  • Fabiana Renzi
  • Xianting Li
  • Adam Schaffner
  • Pravin Kumar Ankush Jagtap
  • Karsten Boldt
  • Felix von Zweydorf
  • Katja Gotthardt
  • Donald D Lorimer
  • Zhenyu Yue
  • Alex Burgin
  • Nebojsa Janjic
  • Michael Sattler
  • Wim Versées
  • Marius Ueffing
  • Iban Ubarretxena-Belandia
  • Arjan Kortholt
  • Christian Johannes Gloeckner

Leucine-rich repeat kinase 2 (LRRK2) is a large, multidomain protein containing two catalytic domains: a Ras of complex proteins (Roc) G-domain and a kinase domain. Mutations associated with familial and sporadic Parkinson's disease (PD) have been identified in both catalytic domains, as well as in several of its multiple putative regulatory domains. Several of these mutations have been linked to increased kinase activity. Despite the role of LRRK2 in the pathogenesis of PD, little is known about its overall architecture and how PD-linked mutations alter its function and enzymatic activities. Here, we have modeled the 3D structure of dimeric, full-length LRRK2 by combining domain-based homology models with multiple experimental constraints provided by chemical cross-linking combined with mass spectrometry, negative-stain EM, and small-angle X-ray scattering. Our model reveals dimeric LRRK2 has a compact overall architecture with a tight, multidomain organization. Close contacts between the N-terminal ankyrin and C-terminal WD40 domains, and their proximity-together with the LRR domain-to the kinase domain suggest an intramolecular mechanism for LRRK2 kinase activity regulation. Overall, our studies provide, to our knowledge, the first structural framework for understanding the role of the different domains of full-length LRRK2 in the pathogenesis of PD.

Original languageEnglish
Pages (from-to)E4357-E4366
Number of pages10
JournalProceedings of the National Academy of Sciences of the United States of America
Volume113
Issue number30
Publication statusPublished - 26-Jul-2016

    Keywords

  • LRRK2, Parkinson's disease, structural modeling, EM, CL-MS, SMALL-ANGLE SCATTERING, STRUCTURE PREDICTION, ELECTRON-MICROSCOPY, KINASE-ACTIVITY, SECONDARY STRUCTURE, MASS-SPECTROMETRY, HIGH-RESOLUTION, CROSS-LINKING, ROC DOMAIN, DISEASE
Related Press / Media
  1. Parkinson-eiwit geeft structuur prijs

    Arjan Kortholt

    28/06/2016

    1 item of media coverage

    Press/Media: Public Engagement ActivitiesPopular

View all (1) »

View graph of relations

ID: 33413232